Flupenthixol decanoate (fluanxol depot) in the treatment of chronic schizophrenic patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005260:Female; D005475:Flupenthixol / Q000031:analogs & derivatives / Q000627:therapeutic use*; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D013892:Thioxanthenes / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D013892:Thioxanthenes; D014149:Tranquilizing Agents; C007761:flupenthixol decanoate; D005475:Flupenthixol